Scarborough Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $317K | Buy |
1,707
+63
| +4% | +$11.7K | 0.06% | 72 |
|
|
2025
Q1 | $344K | Buy |
1,644
+74
| +5% | +$15.5K | 0.05% | 97 |
|
|
2024
Q4 | $279K | Buy |
1,570
+463
| +42% | +$82.3K | 0.04% | 101 |
|
|
2024
Q3 | $219K | Buy |
1,107
+4
| +0.4% | +$790 | 0.04% | 81 |
|
|
2024
Q2 | $189K | Buy |
1,103
+12
| +1% | +$2.06K | 0.08% | 52 |
|
|
2024
Q1 | $199K | Buy |
1,091
+33
| +3% | +$6.01K | 0.09% | 47 |
|
|
2023
Q4 | $164K | Buy |
+1,058
| New | +$164K | 0.03% | 83 |
|